Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Talphera, Inc

Clinical trials sponsored by Talphera, Inc, explained in plain language.

Talphera, Inc. TLPH NASDAQ

A specialty pharmaceutical company developing acute care therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New hope for dialysis patients who can't use standard blood thinners

Disease control Recruiting now

This study tests a drug called Niyad as a blood thinner for people with acute kidney injury who need continuous dialysis but cannot use the standard drug heparin or are at high risk for bleeding. About 70 participants will receive either Niyad or a placebo to see if it safely pre…

Phase: NA • Sponsor: Talphera, Inc • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC